Abstract
Active T cell recognition of islet antigens has been postulated as the pathogenic mechanism in human type 1 diabetes, but evidence is scarce. If T cells are engaged, they are expected to display increased clonal size and exhibit a T helper (Th)1/Th2 differentiation state. We used a peptide library that covers tyrosine phosphatase IA-2, a target antigen expressed in pancreatic beta cells, to probe 8 diabetic patients and 5 HLA-matched controls. When tested in a high resolution IFNgamma/IL-4 double color ELISPOT assay directly ex vivo, the number of IA-2-reactive IFNgamma producing cells was 17-fold higher in patients than in controls and IL-4 producing cells were not present. An average of 9 peptides was recognized in the patients vs. one in the controls. Determinant recognition primarily involved CD4+ cells and showed high variability among the patients. Furthermore, anti-CD28 antibody signal enhances quantitative assessment of effector T cells in T1D patients. In vitro expansion with peptides and IL-2 results in detection of responding cells in the controls and loss of disease specificity of the T cell response. Together these data provide strong evidence for the active targeting of IA-2 by Th1 memory effector cells in human t...Continue Reading
References
Jul 9, 1992·Nature·P V LehmannE E Sercarz
Sep 1, 1992·European Journal of Immunology·H YagiM Harada
Jan 1, 1991·The Journal of Experimental Medicine·S Ehlers, K A Smith
Oct 1, 1987·The Journal of Experimental Medicine·A BendelacJ F Bach
Nov 1, 1994·Diabetes·I Durinovic-BellòD J Schendel
May 1, 1994·DNA and Cell Biology·M S LanA L Notkins
Dec 1, 1993·European Journal of Immunology·J KatzD Mathis
Sep 24, 1993·Cell·J D KatzD Mathis
Sep 1, 1996·Diabetes·B O Roep
Oct 1, 1996·Diabetologia·S GenoveseE Bonifacio
Sep 18, 1997·Immunology Today·R B Effros, G Pawelec
Nov 14, 1997·Diabetes·P J BingleyE A Gale
Jun 6, 1998·The Journal of Experimental Medicine·A J McMichael, C A O'Callaghan
May 6, 1998·Diabetes·T M EllisM A Atkinson
Jun 3, 1998·Autoimmunity·I Durinovic-Belló
Feb 23, 1999·Diabetologia·R D LeslieA L Notkins
Jun 26, 1999·Diabetologia·M StrebelowM Ziegler
Oct 28, 1999·Nature·F SallustoA Lanzavecchia
Nov 24, 1999·The Journal of Clinical Investigation·M PeakmanR M Chicz
Jun 27, 2000·Diabetes·C J HawkesB O Roep
Oct 21, 2000·Journal of Autoimmunity·S BaekkeskovS Kash
Mar 1, 2002·Journal of Autoimmunity·Ivana Durinovic-BellóAnette-G Ziegler
Citations
Apr 7, 2010·Diabetologia·L G Petrich de MarquesiniC M Dayan
May 5, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Patrick A OttPaul V Lehmann
Nov 1, 2005·Cellular Immunology·Stefan QuastPaul V Lehmann
Sep 16, 2015·Current Diabetes Reports·John W McGintyEddie A James
Apr 25, 2016·Cancer Immunology, Immunotherapy : CII·Ioana MoldovanPaul V Lehmann
Nov 25, 2005·Diabetes·Ivana Durinovic-BellóConstantin Polychronakos
Feb 3, 2015·Cells·Jodi HansonPaul V Lehmann
Jan 6, 2018·Cells·Alexander LehmannPaul V Lehmann
Jun 27, 2008·Transplantation·Sofia CasaresTeodor D Brumeanu
Jul 21, 2012·Molecular Biology Reports·Qijuan WangMaosun Fu
Feb 24, 2006·Pediatric Research·Takashi HigashideTsunekazu Yamano
Feb 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Junbao YangWilliam W Kwok
Apr 8, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·MyLinh DangHoward W Davidson